nach oben

Erschienen in:

01.01.2021 | News item

Sibutramine-induced AEs due to adulterated products

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Despite the withdrawal of sibutramine from the market in Singapore, sibutramine-induced adverse events (AEs) are continuing to be reported due to illegal use in adulterated products such as slimming products, says the Singapore Health Sciences Authority (HSA). …

HSA - Health Sciences Authority. Characteristics of sibutramine-induced adverse events due to adulterated products. Internet Document : 10 Dec 2020. Available from: URL: https://www.hsa.gov.sg/announcements/safety-alert/characteristics-of-sibutramine-induced-adverse-events-due-to-adulterated-products

Titel: Sibutramine-induced AEs due to adulterated products
Publikationsdatum: 01.01.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-87829-3

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Sibutramine-induced AEs due to adulterated products

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Bismuth-salicylate/calcium-carbonate/methylprednisolone

Ferrous sulfate

Amikacin/cotrimoxazole

Ampicillin

Cidofovir/hyaluronic acid

Immunosuppressants